Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report)’s stock price traded down 4.2% during mid-day trading on Friday . The company traded as low as GBX 0.12 ($0.00) and last traded at GBX 0.12 ($0.00). 11,402,242 shares were traded during trading, an increase of 22% from the average session volume of 9,326,041 shares. The stock had previously closed at GBX 0.12 ($0.00).
Oxford Cannabinoid Technologies Trading Down 4.2 %
The company’s 50-day moving average is GBX 0.12 and its two-hundred day moving average is GBX 0.14. The stock has a market capitalization of £1.25 million, a P/E ratio of -53.10 and a beta of 0.82.
Oxford Cannabinoid Technologies Company Profile
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
Featured Stories
- Five stocks we like better than Oxford Cannabinoid Technologies
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Buy P&G Now, Before It Sets A New All-Time High
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Stock Average Calculator
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
